Drugs / JWK008
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06519552 | Jul 2024 → Jun 2026 overdue | mucopolysaccharidosis type 1 | West China Hospital | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JWK008 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06519552 ↗ |
| Route | Intravenous | “Single intravenous infusion administration” NCT06519552 ↗ |